Vimarsana
Biggest News Aggregation in the World

Kyle Gano News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kyle Gano. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kyle Gano Today - Breaking & Trending Today

Neurocrine Biosciences to Participate at Investor Conferences in June - Vimarsana News

Neurocrine Biosciences to Participate at Investor Conferences in June

Jefferies Global Healthcare Conference on June 5 in New York

Neurocrine founder-CEO Gorman to retire in October - Vimarsana News

Neurocrine founder-CEO Gorman to retire in October

(Reuters) - Neurocrine Biosciences CEO Kevin Gorman will retire on Oct. 11 after three decades with the company that he founded and will be succeeded by insider Kyle Gano. Gorman founded Neurocrine in 1992 and held several leadership positions befo...

Source: whbl.com
Exploring Major Health News Updates: Abortion Pill Law, Bird Flu Vaccines, and Weight-Loss Drugs - Vimarsana News

Exploring Major Health News Updates: Abortion Pill Law, Bird Flu Vaccines, and Weight-Loss Drugs

Latest health news includes Louisiana's reclassification of abortion pills as controlled substances, the effectiveness of bird flu vaccines in laying hens, and rising forecasts for weight-loss drug sales. Other updates cover M&A deals, CEO retirements, Neuralink's brain implant study, and WHO's push for pandemic response rules.

Brokerages Set Neurocrine Biosciences, Inc. (NASDAQ:NBIX) PT at $137.92 - Vimarsana News

Brokerages Set Neurocrine Biosciences, Inc. (NASDAQ:NBIX) PT at $137.92

Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twenty-three analysts that are covering the firm, Marketbeat reports. Six analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. The average twelve-month target price among […]

Source: wkrb13.com
Assenagon Asset Management S.A. Lowers Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - Vimarsana News

Assenagon Asset Management S.A. Lowers Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Assenagon Asset Management S.A. lowered its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 46.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 315,560 shares of the company’s stock after selling 268,979 shares during the quarter. Assenagon Asset Management […]